Ultragenyx Pharmaceutical Inc. (RARE) — Institutional Holders, Q2 2026 (page 4)
311 institutional investment managers reported a RARE position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $3.5B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 301 to 311. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
RARE 13F holders ranked 301–311 of 311
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 301 | Truvestments Capital#301 · 23 sh | 23 | $768.00 | <0.01% | 0.0% |
| 302 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT#302 · 22 sh | 22 | $712.00 | 0.00% | 0.0% |
| 303 | CVA Family Office#303 · 21 sh | 21 | $701.00 | <0.01% | New |
| 304 | Bare Financial Services#304 · 20 sh | 20 | $668.00 | <0.01% | New |
| 305 | MV CAPITAL MANAGEMENT#305 · 19 sh | 19 | $635.00 | <0.01% | +5.6% |
| 306 | WPG Advisers#306 · 11 sh | 11 | $367.00 | <0.01% | 0.0% |
| 307 | Godfrey Financial Associates#307 · 8 sh | 8 | $267.00 | <0.01% | 0.0% |
| 308 | Cromwell#308 · 7 sh | 7 | $234.00 | <0.01% | 0.0% |
| 309 | Activest Wealth Management#309 · 1 sh | 1 | $33.00 | — | 0.0% |
| 310 | Hughes Financial Services#310 · 1 sh | 1 | $33.00 | 0.00% | 0.0% |
| 311 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#311 · 101,471 sh | 101,471 | — | — | -3.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.